Trastuzumab for HER2-positive early stage breast cancer : a meta-analysis of individual patient data from 13,864 women from seven randomised trials

Richard Gray, Early Breast Cancer Trialists' Collaborative Group (EBCTCG), David A Cameron

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalThe Lancet Oncology
Early online date30 Jul 2021
Publication statusE-pub ahead of print - 30 Jul 2021

Cite this